Saudi Minister of Commerce Meets Head of Moroccan Government, Six Ministers to Discuss Joint Cooperation    Wall Street Closing    stc Launches Center3 to Enhance Digital Economy Growth in Saudi Arabia    Saudi Arabia on the World Heritage Map    Asian Shares Rise    Saudi Arabia's Trojena to host 2029 Asian Winter Games    SFDA wins Prism Award for applying practices to enhance HR leadership skills    IMF Chief: Saudi economy a bright spot amid global crises MoU inked to establish IMF regional office in Riyadh    MEP, GASTAT sign MoU to enhance use of data in development of economic policies    Elon Musk under fire for inflammatory Ukraine Twitter comments    North Korea fires ballistic missile over Japan    Ukraine tank breakthrough in south toward Kherson    Danish queen 'sorry' after stripping grandchildren's titles    Saudi National Music Band to perform in Paris Friday    Riyadh symposium underscores need to globalize traditional Saudi dish Jareesh    Weather Forecast for Tuesday    Five International Financial Institutions Join the Primary Dealers Program of the Government's Local Debt Instruments    OIC Secretary General Receives Kazakh Consul in Jeddah    KSrelief Distributes 455 Food Baskets in Khartoum State, Sudan    Chairman of Board of Directors of Saudi Esports Federation Highlights the National Gaming and Esports Strategy    Saudi Arabia retains its seat in ITU Council by international consensus    Minister of Human Resources and Social Development Patronizes 5th International Conference on Occupational Safety and Health    RCU launches Safar art exhibition at AlUla airport    Saudi Stock Exchange Main Index Ends Trading Higher at 11,607.96 Points    Fans 'died in the arms' of players in Indonesia stadium crush    Fans of Sydney United 58 condemned for Nazi salutes during Australia Cup final    Saudi Arabia to host World Petroleum Congress in 2026    King, Crown Prince congratulate German president on Unity Day    Tadawul All Share Index Decreases by 0.79%, Equity Market Capitalization Reaches SAR 10,832.85 Billion at End of 1st Nine Months 2022    Al-Manea: Selling gold in installments is not permissible    174 dead in Indonesian football stadium crush    15 cups of Saudi coffee in a day are enough!    Riyadh hosts first Saudi Games on Oct. 27    19 women, 2 men qualify as Kingdom's first yogasana referees    Movies return to Kashmir with Hrithik Roshan-starrer    Islamic Minister Al-Sheikh: Juristic judgment catalyst to salvage Islamic Ummah    Culinary Arts Commission Registers 13 Foods on Slow Food List of Endangered Food    72% of Children Globally have been Victims of Cyber Threats    Saudi National Football Team Continues Preparations for Friendly Match against Ecuador    Saudi Futsal Team Beats San Marino, Wins Silver in Croatian International Championship    During 2nd Global AI Summit.. AI-powered Early Breast Cancer Detection Program Launched    Triple talaq: India Muslim women in limbo after instant divorce ruling    Film Commission Reviews Film Industry Prospects in Saudi Arabia at Venice International Film Festival    Saudi national volleyball team loses to Kyrgyzstan in Asian Challenge Cup final    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FDA authorizes third coronavirus vaccine in US
Published in The Saudi Gazette on 28 - 02 - 2021

The US Food and Drug Administration (FDA) authorized Johnson & Johnson's COVID-19 vaccine Saturday. It is the first single dose COVID-19 vaccine available in the US, and is one that "checks nearly all the boxes."
The FDA announced in a statement that it has issued "an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
"The EUA allows the Janssen COVID-19 Vaccine to be distributed in the US for use in individuals 18 years of age and older," it added.
In this regard, Acting FDA Commissioner Janet Woodcock said "The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agency's rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization."
For his part, President Joe Biden said, "This is exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis. We know that the more people get vaccinated, the faster we will overcome the virus, get back to our friends and loved ones, and get our economy back on track."
"I want to be clear: This fight is far from over," he warned. "As I have said many times, things are still likely to get worse again as new variants spread, and the current improvement could reverse. There is light at the end of the tunnel, but we cannot let our guard down now or assume that victory is inevitable. We must continue to remain vigilant, act fast and aggressively," he stressed.
The FDA had already approved vaccines developed by Pfizer-BioNTech and Moderna.
With more than 28.5 million confirmed COVID-19 cases and over 511,000 reported deaths in the US since the start of the pandemic, and while the demand for vaccine still far exceeds supply, these vaccines can't come soon enough.
"A third safe and effective vaccine is very welcome news," Andy Slavitt, the White House's senior for COVID Response, tweeted on Friday.
"We need a vaccine that can be quickly mass produced," Dr. Greg Poland, head of the Mayo Clinic's Vaccine Research Group, said Friday. "We'd want to see a reasonable duration of efficacy and protection.
The vaccine was tested in more than 44,000 people in the US, South Africa and Latin America. Globally, it was 66.1% effective against moderate to severe/critical COVID-19 at least four weeks after vaccination, according to an FDA analysis. In the US, it is considered 72% effective, and offered 86% protection against severe forms of the disease.
"One dose will keep you out of the hospital, keep you out of the intensive care unit, and keep you out of the morgue," Dr. Paul Offit, a vaccine adviser to the FDA, told CNN's Wolf Blitzer on Friday. The vaccine comes with few side effects, most of which are mild, including pain at the injection site, headache, fatigue and muscle pain.
Overall, non-fatal serious adverse events were infrequent, according to the FDA's analysis, and there were no reported cases of anaphylaxis following vaccination in the trial. There have been a small number of severe allergic reactions with the Moderna and Pfizer/BioNTech vaccines.
More research is needed, but the FDA analysis also hinted that the J&J vaccine may help prevent asymptomatic infections. A January study from the CDC showed that most coronavirus cases are spread by people without symptoms. If a vaccine prevented asymptomatic infection, it might help reduce opportunities to transmit the disease — not just keep the vaccinated from getting sick.
With so much positive data, an independent group of advisers voted unanimously on Friday to recommend the emergency use authorization of the J&J vaccine. — Agencies


Clic here to read the story from its source.